Previous 10 | Next 10 |
How to Find The Best Biotech Penny Stocks to Buy in 2021 Biotech penny stocks have become some of the most popular stocks to watch in 2021. This began at the start of the pandemic after many leading penny stocks in the biotech industry fell in value substantially. While this made se...
This selection article continues a four-year ad hoc test of published studies that the Russell reconstitution generates excess risk-adjusted returns. In my prior three-year study from 2017, abnormal gains were identified from the annual June rebalancing and some profitable strategies ...
Diamond hands have gone 10-2 on the steering wheel on yet another stock. This time the target of communities like /r/WallStreetBets was Atossa Therapeutics (NASDAQ:ATOS), a Seattle-based biotech company specializing in clinical-stage breast cancer treatments. The stock pri...
Shares of Atossa Therapeutics Inc. (NASDAQ:ATOS) traded at a new 52-week high today of $9.80. So far today approximately 6.9 million shares have been exchanged, as compared to an average 30-day volume of 18.4 million shares. Over the past year, Atossa Therapeutics Inc. has traded in a ra...
supparsorn/iStock via Getty Images The clinical-stage biopharma company Atossa Therapeutics ([[ATOS]] +12.1%) seems on track to continue its eight-day winning streak with more than a tenth of gain in the morning hours. Last week, the company announced that it will be part of Russell 2000 and ...
Gainers: Osmotica Pharmaceuticals (OSMT) +38%, Star Equity (STRR) +16%, Atossa Therapeutics (ATOS) +15%, Vor Biopharma (VOR) +12%, Rezolute (RZLT) +10%.Losers: Theravance Biopharma (TBPH) -8%, Corbus Pharmaceuticals (CRBP) -8%, Kaleido Bi...
The Seeking Alpha Quant System alerted Premium users of this hidden stock, and in a month the stock prices shot up 120%. This stock carries a short interest of 11%. If the company continues to do well, then the stock could see more significant upside as the shorts cover. Start you...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Today, investors in Atossa Therapeutics (NASDAQ: ATOS ) and ATOS stock are seeing double-digit gains on a very good day in the stock market. Speculative plays are once again in focus for investors. According...
Gainers: Kaleido Biosciences (KLDO) +15%, Pieris Pharmaceuticals (PIRS) +14%, Arcus Biosciences (RCUS) +14%, Compugen (CGEN) +14%, Atossa Therapeutics (ATOS) +14%.Losers: Portage Biotech (PRTG) -23%, Rite Aid (RAD) -14%, 4D Mole...
Gemini Therapeutics (GMTX) -31% after initial data from mid-stage GEM103 AMD study.Second Sight Medical Products (EYES) -18% after secures $50M capital via equity raiseTorchlight Energy Resources (TRCH) -17%.Alfi (ALF) -16% stock pulls back from buyback-fueled ra...
News, Short Squeeze, Breakout and More Instantly...
Atossa Therapeutics Inc. Company Name:
ATOS Stock Symbol:
NASDAQ Market:
Atossa Therapeutics Inc. Website:
SEATTLE, July 22, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”) today announced that the 12-patient 80mg pharmacokinetic (PK) run-in cohort of the Phase 2 EVANGELINE (Endoxifen Versus exemestANe GosEreLIn) study has fully...